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Abstract—An experimental investigation is carried out to
develop a novel approach to cryosurgery, where laser heating
counteracts tissue freezing to better confine damage to the
targeted cancerous tissue within a lethal low-temperature
isothermal boundary—an approach we refer to as laser-
assisted cryosurgery (LAC). The advantage of this procedure
relative to conventional cryosurgery assisted with urethral
warmers or cryoheaters is that laser heating provides
volumetric rather than superficial heating, which leads to
deeper penetration, more homogeneous tissue protection and
better demarcation of the destructive freezing effect to a well-
defined targeted volume. Tissue viability assays are per-
formed using green fluorescence protein (GFP) as a viability
marker and correlated with temperature history after
performing LAC procedures on ex vivo mice hepatic tissue.
The limit for cell denaturation at the irradiated surface
predicted by GFP analysis is further confirmed using reverse
transcription polymerase chain reaction (RT-PCR). In addi-
tion, the correlation between GFP fluorescence and cell
viability and loss of GFP fluorescence in non-viable cells has
been tested and validated by histological analysis using a
standard cell viability measuring method (hematoxylin and
eosin staining). Analysis of our experimental measurements
show that reproducible thermal gradients (of 236 C/cm) and
predictable tissue necrosis can be reliably produced by LAC
without exceeding temperature thresholds for cell denatur-
ation (of Tsurf  48 C) beyond preset tissue boundaries
(with resolution of 0.1 C/mm). The results have shown the
feasibility of controlling temperatures at specified tissue
locations to prevent hyperthermal or freezing damage.
Keywords—Cryoablation, Prostate cancer, RT-PCR.
NOMENCLATURE
d Distance (mm)
SD Standard deviation
t Time (s)
T Temperature (C)
TC Thermocouple
Greek Letters
d Thickness of protection layer (mm)
la Absorption coefficient (mm
21)
Subscripts
Amb Ambient
Cryo Cryoprobe
Surf Surface
Th Threshold
INTRODUCTION
Cryosurgery is the infliction of a lethal freezing
injury achieved by the contact of one or more metallic
probes at low subzero temperatures with a target
tumor tissue. Prostate cryosurgery was the first mini-
mally invasive cryosurgical procedure to pass from the
experimental stage and become a routine surgical
treatment.25 While the main objective during a cryo-
surgical procedure is to ensure tissue destruction
within the cryolesion, the greatest challenge is on
how to spare the surrounding healthy tissues from
cryoablation. In order to overcome this difficulty and
with the aid of recent technological developments, the
total number of cryoprobes used during a cryosurgical
procedure has been increased because of a considerable
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reduction in cryoprobe size and an increase in the
ability to control the freezing rate.6,27,30 Recent
improvements in imaging devices that help to monitor
the freezing process, such as ultrasound or MRI,
have further enhanced the popularity of cryosur-
gery.16,18,30,36,37 Also, numerical optimization tech-
niques have been developed1,2,19,36,37 so that the
optimal number and placement of cryoprobes mini-
mizes collateral damage.
During prostate cryosurgery, urethral warmers
(double-pipe water heat exchangers embodied in a
standard catheter) are used for routine cryosurgery
control8,28 to protect the urethral wall from damage.
A recent investigation suggests that cryoheaters
(temperature-controlled electrical heaters) can be more
effective in protecting the urethral surface and better
shaping the frozen region to maximize destruction of
the unhealthy tissue.29 Although this may greatly
improve the procedure effectiveness, the success of
cryosurgery is still very dependent on the experience
and good judgment of the surgeon, who monitors the
growth of the ice ball and determines its maximum
size.20 In this regard, if temperatures were maintained
above the damage threshold within healthy tissue at all
times, independent of the cooling application time,
great progress would be achieved.
Recently, a new means of cryosurgery control was
suggested,31,32 where laser heating counteracts tissue
freezing to better confine damage to the targeted
cancerous tissue within a lethal low-temperature iso-
thermal boundary—an approach referred to as laser-
assisted cryosurgery (LAC). The thermal confinement
achieved by LAC was compared against that achieved
by warmers or cryoheaters, demonstrating that LAC
was more efficient in terms of protecting a much
thicker layer of tissue. In LAC, the frozen region can
be shaped to selectively destroy malignant tissue. This
is achieved by strategically inserting minimally invasive
optical fibers into predetermined sites to supply the
volumetric heating needed to prevent unwanted tissue
freezing. This approach is very practical for worst case
scenario for tissue damage, which occurs when the
steady-state temperature is reached in the region of
interest, which is when the freezing front gets closer to
the heating boundary. The advantage of LAC com-
pared with traditional methods is that it provides
protection to certain regions of tissue from being fro-
zen without limiting so severely the application of the
cryoprobe. In addition, if only a portion of the pros-
tate needs to be destroyed, cryoablation of portions of
healthy prostate tissue can be avoided by effectively
localizing optical fibers inside the prostate. This
approach cannot be employed using cryoheaters or
warmers. The major impact of a successful LAC pro-
cedure is that there would be no need to stop the
freezing process prior to achieving the target lethal
temperature. In addition, a more uniform and lower
temperature inside the tumor could be achieved by
freezing to temperatures below the lethal isotherm4,12
and effectively confining the frozen tissue within preset
boundaries.
The correlation between loss of GFP fluorescence
and loss of cell viability is well established and has been
previously tested and validated.17 GFP was used to
monitor metabolic activity and the authors point out
that this detection method should be used as a stan-
dard assay.38 The GFP-based assay was compared
against commercial viability DNA-binding dyes
(SYTO9-PI), and results showed that the GFP-based
assay improves reliability for the assessment of cell
viability with no marked difference in sensitivity.18
Also, GFP was used as a reporter for cell viability and
the authors point out that it offers greater simplicity,
easier monitoring, enhanced biosafety, and lower cost
than the luciferase reporter assay.9 The results
obtained with the GFP viability assay method were
confirmed by comparing them against Propidium
Iodide and Annexin V staining.35 The authors reported
that GFP can be used as an excellent marker for
detection of necrosis by measuring the decrease of
GFP fluorescence intensity. In addition, the validity of
GFP viability assays for cryobiological applications
has been established by comparing the results against
common viability indicators (trypan blue and ethidium
bromide) with excellent correlation coefficients of 0.97
and 0.95, respectively.11 As GFP accumulates in the
cytoplasm of the normally metabolizing transfected
cells, damage to the plasma membrane due to heating
or freezing insults results in leakage of cell contents,
including GFP.3 Denaturation of the GFP results in a
loss of fluorescence, primarily because the chromo-
phore is no longer encapsulated and protected.7,26
Since viable cells express GFP continuously, loss of
GFP fluorescence in necrotic cells is used to correlate
the recorded temperature histories with the outcome of
viability after a LAC procedure.
The aims of the present investigation are to
(a) assess the feasibility of LAC to limit cryoinjury to a
predefined region and (b) correlate tissue viability with
local tissue temperature histories on ex vivo mice
hepatic tissue after exposed to LAC procedures. For
this purpose, we use mice transfected with green fluo-
rescence protein (GFP). As GFP fluorescence in non-
viable cells is lost when cell membranes are damaged
either by freezing or heating insults, GFP is used as a
marker for tissue viability by relying on the expression
and retention of GFP. The maximum temperature at
which thermal necrosis occurs at the irradiated surface
during LAC is further confirmed using reverse tran-
scription polymerase chain reaction assays.
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The ultimate applicability of this research is to
destroy with precision any tumor regardless of its size
and shape by avoiding postsurgical complications and
malignancy recurrence.
MATERIALS AND METHODS
Sample Preparation
LAC was performed ex vivo on fresh mouse liver
samples. Cryothermia was induced to the liver of
transgenic mice expressing GFP in all of their cells
using a 7.7-mm-diameter cylindrical cryoprobe cooled
by internally circulating liquid nitrogen. The temper-
ature of the cryoprobe tip (Tcryo = 2188 C) was
determined by placing a thermocouple at the tip’s
surface. For freezing, the cryoprobe was placed care-
fully on the surface of one side of the tissue sample
after being precooled. A Nd:Yag Laser system (Cool-
Touch, NS130C) with a wavelength of 1320 nm and a
maximum power of 10 W was used to irradiate and
induce volumetric heating to the tissue from one end.
For these experiments, the laser light was attenuated
with optical density filters to the required energy
(43 mJ, pulse duration 300 ls, 20 Hz, spot size
2.6 mm). The absorption coefficient in mouse hepatic
tissue for a wavelength of 1064 nm is of la = 0.13
(mm21).24 Although an exact assessment of the optical
properties of mouse hepatic tissue was not performed
for a wavelength of 1320 nm, since in the near-infrared
the absorption decreases with shorter wavelengths due
to tissue water content, the thermocouples were not
considered as light absorbers because they were
inserted at a distance from the irradiated surface that’s
larger than the penetration depth of light in mouse
liver tissue at a wavelength of 1320 nm.
The resultant temperature histories produced within
the tissue specimens during a LAC procedure were
determined experimentally with an array of four sep-
arate 33-gage needle copper-constantan thermocouple
probes (Omega Engineering, HYP0 mini-hypodermic
probes) connected to a data acquisition system. The
thermocouple probes were held in position by an
acrylic lid, and the vertical positions of the thermo-
couples were adjusted with depth stops so that all tips
were brought to the same plane orthogonally to the lid
at the depth of the laser lightguide axis. The in situ
temperature measurements were acquired at 2.5 Hz,
displayed in real-time and logged into a PC for further
analysis. Figure 1 shows a schematic diagram of the
experimental setup used to measure the temperature
response of tissues at selected points during a LAC
procedure.
LAC Procedure
All procedures employed in this study were
approved by the Institutional Animal Use and Care
Committee of the University of California, Riverside:
Protocols A-20080013 and A-20080019. After the ani-
mals were euthanized by CO2 gas asphyxiation, the
liver was excised and carefully cut with a custom cut-
ting tool to a predetermined rectangular block of
10 9 6 9 2.6 mm.
Hepatic tissue was selected because it is one of the
largest organs of the mouse. A tissue block size of 1 cm
was chosen because it allowed measurements of the
temperature history at four different locations inside
the tissue sample to be taken. Rectangular tissue
FIGURE 1. Schematic of the experimental setup.
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samples were used for all the experiments in order to
avoid variations in their dimensions that could lead to
significant variations of the position of Tth from one
experiment to the other.31,32 The tissue sample was
carefully placed and fitted with the miniature needle
thermocouples in the disassembled transparent acrylic
chamber shown in Fig. 1 and detailed in Fig. 2. The
needle thermocouples TC1, TC2, TC3, and TC4 were
mounted equidistant from the cryoprobe tip at: d = 2,
4, 6, and 8 mm, respectively. Afterward, the chamber
was closed and the tissue sample was slightly com-
pressed so that there was no variance in its dimensions
from one experiment to another. The cryolesion was
created using a single freeze/thaw cycle, and through-
out the experiment, ice ball progression was monitored
with a digital camera. The temperature data from the
LAC procedure was compiled to evaluate the freezing
front propagation and to correlate the thermal history
with the resulting cryoinjury, seeking to define the so
called ‘‘lethal temperature.’’
Reverse Transcriptase Polymerase Chain
Reaction Analysis
To quantify the amount of hyperthermic damage
induced to the cells at the irradiated surface for dif-
ferent laser settings, reverse transcriptase polymerase
chain reaction (RT-PCR) analysis was performed. To
test the integrity of the RNA of LAC-treated samples
and untreated controls, RNA was isolated from
100-lm thick slices taken from the laser-irradiated
surface after 2 h of being irradiated and RNA was
extracted using the QIAGEN RNeasy mini kit
(QIAGEN) according to the instructions of the man-
ufacturer. RNA yield and purity was analyzed using a
NanoDrop 1000 spectrophotometer. RT-PCR expres-
sion of b-actin was determined in tissue samples after
LAC procedures and appropriate controls using
conventional RT-PCR. Briefly, 50 ng total RNA was
reverse transcribed using oligo(dT)15 primer, 1 U of
RNasin ribonuclease inhibitor and 1 U of AMV
reverse transcriptase system (PromegaTM) for 10 min
at 70 C, 5 min at 4 C, 60 min at 42 C, and 5 min at
95 C. A 154 pb fragment of b-actin was amplified
with Taq DNA polymerase (Biolabs) using 100 ng of
each cDNA and 300 lM primers (forward primer:
5¢-CCTCTATGCCAACACAGT-3¢; reverse primer:
5¢-AGCCACCAATCCACACAG-3¢). PCR conditions
were based on the recommendations of the manufac-
turer. An initial cycle at 95 C for 1 min, followed by
35 cycles of 30 s at 95 C, 30 s at 55 C, and 120 s at
60 C. The amplicon was resolved with electrophoresis
on agarose gel (2%) and stained with ethidium bro-
mide. A target temperature of 3 C for TC4 was found
to be the value that maximizes the thickness of the
protection layer without surpassing the lethal thresh-
old for cell viability due to hyperthermia.
Time Sequence for a LAC Procedure
The complete LAC procedure lasts a total of 700 s
and consists of a single freeze/thaw cycle. The freezing
process involves a single 300-s freeze period (consisting
of an initial 200-s transient and a 100-s steady-state)
followed by a 400-s thawing period. Regulated laser
power was supplied during the transient freezing and
thawing periods, while constant laser power was sup-
plied during steady-state heat transfer. After thawing,
the samples were stored in Dulbecco’s Phosphate
Buffered Saline (DPBS) and analyzed for viability
using GFP as a viability marker.
Power Regulation/Modulation and Establishment
of Steady-State
During LAC, the power needed to achieve the
desired protection depends on the thermal/optical
FIGURE 2. (a) Disassembled acrylic chamber (upper view) with the miniature needle thermocouples at even and known distances.
(b) After the tissue sample is placed and the thermocouples inserted, the chamber is closed.
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properties of the tissue and the separation between the
cryoprobe and the laser-irradiated surface. Since the
time scale for energy transport by conduction in tissue
is different to that for laser energy absorption, the
cryoprobe and the laser must be turned on at different
times and the laser energy must be supplied gradually
during the procedure. For simplicity, during a LAC
procedure the laser power delivered remains fixed to a
preset value and, to avoid undesirable heating damage,
the laser beam is blocked using a mechanical device
that works as a shutter that switches the laser on or off.
The appropriate timing for laser irradiation/suppres-
sion was designed to maintain the maximum tissue
temperature below that known to produce thermal
necrosis (43–48 C).21,22,33,34 While the maximum
temperature was expected to be reached at or near the
irradiated surface, it was impractical to use a thermo-
couple placed at that surface for the laser control
feedback because the bead absorbs the laser light
directly and, thus, disrupts the temperature field at that
location. Instead, this temperature feedback was
obtained by using the reading of the thermocouple
located farthest away from the cryoprobe tip
(TC4 = 8 mm). Preliminary tests showed that a target
temperature of TC4 = 3 C was required to maximize
the thickness of the protected tissue and to avoid loss
of fluorescence due to undesired thermal damage at the
irradiated surface. The temperature of the irradiated
surface remained within a viable value (presumably
less than ~48 C), as was confirmed by RT-PCR
analysis performed at the irradiated surface (see
Section Reverse Transcriptase Polymerase Chain
Reaction (RT-PCR) Analysis).
The laser power requirements needed to achieve
the desired protection in the implementation of LAC
had already been addressed.32 Briefly, the cryopro-
cedure starts by turning the cryoprobe on to initiate
the freezing process while the laser is off. During the
transient process, as the freezing front advances away
from the cryoprobe and the temperature at the
opposite end starts to drop, regulated laser irradia-
tion is gradually applied to avoid excessive heating.
As a consequence of the progressive increase in laser
irradiation heating, the freezing front is stopped at
some distance from the irradiated surface and a
steady-state temperature distribution is achieved and
held by supplying constant laser irradiation while
maintaining a target temperature of 3 ± 1 C in TC4.
For the last stage of the cryoprocedure, the cryo-
probe is turned off and the regulated laser irradiation
supplied is gradually decreased so that the target
temperature in TC4 is always maintained. Afterward,
the laser is turned off and the sample is thawed at
room temperature until there are no visible signs of
frozen tissue. Figure 3 shows the normalized laser
power as a function of time required during a com-
plete LAC procedure in order to avoid undesirable
heating at the irradiated surface. Note that although
laser power regulation is performed by blocking the
laser beam with a shutter, this method is sufficient to
control the temperature of the tissue sample without
producing any significant temperature fluctuations
in the overlying volume. Nevertheless, future work
in the implementation of LAC must be aimed
toward the development of an accurate laser power
algorithm that includes a control approach with
optimization.
GFP Viability Assays
Expression of GFP, originally isolated from the
bioluminescent jellyfish Aequorea victoria, represents a
unique method for fluorescent labeling of viable cells.5
An advantage of using GFP fluorescence is that the
tissue can be assayed without altering the system in any
way, other than illuminating with light of the proper
excitation wavelength. GFP fluorescent assays do not
require staining or fixation of the tissue to indicate
viability, but rather rely on the expression of GFP,
where aside from the addition of buffer substrate, no
other processing of the sample is required.
In this work, GFP viability assays are performed
following a LAC procedure by using transgenic mice
expressing GFP in all tissues obtained from The
Jackson Laboratories (Bar Harbor, MD) to accurately
quantify the limits of tissue viability.
FIGURE 3. Normalized laser power as a function of time
required to avoid excessive heating at the irradiated surface
during a complete LAC procedure with a total duration of
700 s starting when the cryoprobe is turned on to initiate the
freezing process. For clarity, the variations in the laser power
supplied by blocking the laser beam with a shutter are not
shown.
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RESULTS
Temperature Recordings
All of the LAC procedures presented were per-
formed using the time sequence previously described.
Figures 4a–4e show the elapsed time required for the
freezing front to travel from the cryoprobe tip to the
sites where the thermocouples were located. Figure 4f
shows how the freezing front is stalled during steady-
state heat transfer (from 200 £ t £ 300 s) at a distance
of d  8.2 mm away from the cryoprobe.
Figure 5 shows the recorded temperature history for
a LAC procedure. The tissue temperatures measured at
various longitudinal positions illustrate the tempera-
ture gradient achieved. The lowest temperature inside
the tissue is achieved at a distance of d = 0 mm at the
cryoprobe tip, while the higher temperature shown for
reference is the ambient temperature Tamb = 25 C.
Figure 6 shows the temperature profile of the tissue
sample during steady-state heat transfer. The temper-
atures shown are expressed as mean ± SD for 200 £
t £ 300 s. The mean and SD were calculated with the
FIGURE 4. (a)–(e) The images illustrate the freezing front advancement during a LAC procedure from the cryoprobe tip at: d 5 0,
2, 4, 6, and 8 mm, respectively. (f) From 200 £ t £ 300 s the freezing front is stalled at d  8.2 mm away from the cryoprobe during
steady-state heat transfer.
FIGURE 5. Tissue temperature measured by the five thermocouples at various longitudinal positions as a function of time during
a LAC procedure. The closer the thermocouples to the cryoprobe are, the steeper is the fall of the tissue temperature upon freezing.
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readings of the thermocouples for each time instant
and the sample size was of 250 for each thermocouple.
Note that the temperature gradients are very steep,
e.g., having a temperature of Tcryo = 2188 C at the
cryoprobe tip while a maximum surface temperature of
Tsurf at a distance of 10 mm away from the cryoprobe
remained within a viable value throughout the whole
LAC procedure.21,22,33,34 Freezing with a shorter
interval was not performed since the temperature
profiles during steady-state would be the same
regardless of the duration of the freezing interval.
Correlation between the temperature histories and the
outcome of viability assays showed that the threshold
of lethal injury after a LAC procedure (Tth  4 C)
was located at a distance of d  8.2 mm away from the
cryoprobe. Note that this value is higher than the le-
thal threshold for conventional cryosurgical proce-
dures (where the lethal threshold occurs over a range
of temperatures from 0 to 250 C).
An analysis of the reproducibility of the resultant
temperature distribution was carried out from repeated
experiments on ex vivo mice hepatic tissue. The resul-
tant temperature profiles in this series of experiments
showed excellent reproducibility, with an error of
<4% in the averaged mean target temperatures and a
SD of <1.4 C. The feasibility of LAC to limit cryo-
injury to a predefined region has been assessed after
correlating tissue viability with local tissue temperature
histories on ex vivo mice hepatic tissue after exposed to
LAC procedures. Results show that reproducible
thermal gradients (of 236 C/cm) and predictable tis-
sue necrosis can be reliably produced by LAC without
exceeding temperature thresholds for cell denaturation
(of Tsurf  48 C) beyond preset tissue boundaries
(with resolution of 0.1 C/mm).
Table 1 shows a comparison between the results of
RNA yields for LAC-treated samples and untreated
controls for different values of the target temperature
measured at TC4. The inverse controls were taken
from the surface where the cryoprobe was placed.
Three replicates of this assay were performed and the
values displayed are normalized values of mean mass
of RNA in ng/lL, the standard error of the mean
(SEM), and the resultant GFP fluorescence. In addi-
tion, 150 pb are amplified from the b-actin gene. The
RT-PCR results show that b-actin expression is
detectable and virtually identical between irradiated
and non-irradiated tissues.
FIGURE 6. Temperature history during steady-state heat transfer. The temperatures displayed are expressed as mean 6 SD for
200 £ t £ 300 s.
TABLE 1. Results of mean RNA yields between LAC-treated
samples and untreated controls expressed as mass of RNA in
ng/lL.
Sample
Normalized
mass of
RNA in ng/lL
Standard
error of the
mean (SEM)
GFP fluorescence
at the irradiated
surface
Control 1 0.000 Yes
TC4 = 3 C 0.963 0.013 Yes
TC4 = 6 C 0.455 0.021 No
TC4 = 35 C 0.061 0.008 No
Inverse control 0.066 0.001 No
The samples are 100-lm thick slices taken from the laser-
irradiated surface and inverse controls were taken from the surface
where the cryoprobe was placed. Data represent averages of three
replicates. LAC-treated samples show the target temperature used
for TC4.
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Viability Assays
After thawing, the samples were stored in DPBS
and assessed with a Leica MZIII Stereo Dissection
Microscope (Diagnostic Instruments, Inc.) coupled to
a digital color/grayscale camera (Pursuit 4 Mp Slider,
Model 16.4) by detecting fluorescence under UV illu-
mination using Spot Advance software (version 4.6).
The recorded images were then analyzed to determine
with precision the thickness of the protected region due
to laser irradiation, the extent of necrotic tissue due to
cryoablation, and the temperatures below which tissue
was cryoablated.
In order to avoid false positive viability assessment
due to a narrow time window after thermal insult, the
appropriate time point needed for lethally affected cells
to lose fluorescence was estimated for both hyper-
thermia and cryoablation. Surprisingly, it was found
that they differ considerably. For the case of temper-
atures above the lethal threshold for cell denaturation
due to hyperthermia, GFP was immediately degraded
and fluorescence was immediately lost. On the other
hand, it was found that the damage induced by freez-
ing was not evident immediately after a LAC proce-
dure. Therefore, the sample had to be stored in DPBS
at room temperature for 5 h before being imaged so
that the transient changes in permeability suggesting
lethal damage lead to loss of GFP fluorescence. This is
a very important issue in cryobiology applications. It
was found that this time window after the thermal
insult was needed after cryoablation. In order to make
sure that fluorescent cells after the time window are
positively alive, the results obtained with the GFP
viability assay method were confirmed by comparing
them against histological analysis using a standard cell
viability method (hematoxylin and eosin staining).
Tissue samples were divided into two main treatment
groups: untreated controls and tissue samples that
underwent a LAC procedure without laser heating.
Both groups were incubated using the same protocol
described above. After the incubation period, tissue
samples from both treatment groups were analyzed for
viability using GFP fluorescence as a viability marker.
After verifying that the control was fluorescing
brightly and that the treated tissue samples had lost
fluorescence due to damage induced by cryoinjury,
formalin fixation was performed. Liver sections
(10 lm) were prepared using a microtome and placed
on glass slides. Standard hematoxylin and eosin (H&E)
stains were employed and histopathologic examination
was determined by light microscopy. Representative
sections from H&E staining in mouse hepatic tissue are
shown in Fig. 7. The histologic appearance of the liver
parenchyma in the control group appeared normal and
showed regular hepatocellular architecture with intact
sinusoidal lining. The structural details are shown in
Fig. 7a. The tissue samples that underwent a LAC
procedure without laser heating revealed homogeneous
severe tissue damage and necrosis at all sites. Figure 7b
illustrates how exposure to temperatures below the
lethal isotherm caused a destructive effect in the liver
with clear histopathological alterations such as sinu-
soidal congestion, hepatocyte congestion, and loss of
cellular morphology. The findings of the present his-
tological investigations corroborated a direct correla-
tion between fluorescent tissue and viable tissue after
the time window. In addition, massive hepatic necrosis
indicating irreversible cell death was apparent in all of
the cryotreated tissue samples that had lost fluores-
cence after the incubation period.
Figure 8 shows the outcome of viability following
LAC. Figures 8a and 8b are two different samples
assayed after identical LAC procedures. On the left
side of the sample, a scale displays the thickness of the
high fluorescence intensity region (d) in mm. In both
cases, d  1.8 mm. The thickness of the high fluores-
cence intensity region was determined by placing the
tissue sample on top of a high resolution scale. Livers
of three additional animals served as controls. The first
FIGURE 7. (a) Photomicrograph of hematoxylin and eosin stains (2003, H&E section) showing normal hepatic parenchyma with
regular hepatocellular architecture and intact sinusoidal lining. (b) Destruction of vascular structures resulting from cryoinjury
indicating hepatic necrosis.
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one was fixed after being excised in 4% formaldehyde
for 5 h at room temperature, then transferred to a 30%
sucrose solution and incubated at 4 C overnight. The
second one was imaged immediately after being excised
and the third control was stored in DPBS and imaged
after 5 h. All the controls showed that all viable cells
were found to be positive for GFP expression. In
addition, formaldehyde-fixed control tissues showed
no degenerative changes and were histologically simi-
lar. Figure 8c shows a control imaged immediately
after being excised displaying the same level of fluo-
rescence than the regions of viable tissue in Figs. 8a
and 8b. Note that in Fig. 8c the lower section of the
control has a slight variation in GFP fluorescence
levels. This occurs because when the samples are
placed at the microscope stage their height is not even
and this results in uneven levels of fluorescence inten-
sity. This also can be seen in Figs. 8a and 8b where the
brightness of the upper necrotic tissue is also dimmer.
Nevertheless, these slight variations in fluorescence
intensity are not significant when observing a clear
demarcation between necrotic and viable tissue.
Figure 8d shows an inverse control imaged after 5 h of
incubation in DPBS after running a LAC procedure
without laser heating. The image illustrates the loss of
GFP fluorescence in non-viable cells. In order to assess
that the incubation in DPBS does not affect fluores-
cence intensity, after identical LAC procedures, the
samples are imaged after 1, 2, 3, and 4 h. A compari-
son between fluorescent intensities of the imaged
samples (not shown) did not show any reduction in
GFP fluorescence due to incubation alone. Figure 9
shows the outcome of viability for the same tissue
sample after a LAC procedure for different levels of
the exposure values (EV) in milliseconds. Detection of
low expression levels of the GFP signal was quantified
by converting the acquired images to grayscale
(16 bits) and assigning a threshold of pixel intensity
that corresponds to at least a 50% reduction of fluo-
rescence relative to the higher peak. Again, although
FIGURE 8. High–low intensity contrast in fluorescence. The sharp contrasts in GFP intensity are directly correlated to cell
viability in that region. (a, b) GFP viability assays showing a demarcated frontier between viable and necrotic tissue in two different
samples assayed after identical LAC procedures. In both cases the thickness of the protected region achieved is the same, and its
estimated value is d  1.8 mm. (c) Control sample imaged immediately after excision. (d) Inverse control imaged after 5 h of
incubation in DPBS after running a LAC procedure without laser heating.
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the levels of fluorescence intensity throughout the
sample show a slight variation, a clear demarcation
between necrotic and viable tissue is evident for all the
EVs. Figure 10 shows a comparison between the tem-
perature history of a LAC procedure (solid lines) and a
LAC procedure without laser heating (dashed lines).
The image clearly shows that steeper gradients can be
achieved using LAC.
DISCUSSION
The success of a cryosurgical procedure today is
very user-dependent. One of the most substantial
challenges in cryosurgery is the incomplete tumor
ablation near the ice ball edge, where tissues are frozen
but not completely destroyed and, thus, are prone to
tumor recurrence.16 Since tumor recurrence after sur-
gery should be precluded at all costs, a safety margin of
1 cm is used to freeze all regions of a small tumor to
lethal temperatures. In prostate cryosurgery, it is
desirable to set a temperature goal of 250 C in all
cancer areas and 240 C at a distance of 1 cm from
the tumor.13,14 However, with traditional cryosurgery
procedures, this recommendation is difficult to follow
in some anatomic locations, such as the prostate gland
with its proximity to the rectum and urethra. Results
of this study indicate that the above potential problems
can be eradicated by LAC implementation. With this
new methodology, the freezing injury is significantly
enhanced by creating very steep temperature gradients
close to the edge of the interface between frozen and
unfrozen tissue. Therefore, a lower temperature inside
the tumor can be achieved by freezing to temperatures
below the lethal threshold with a better enclosure of
the tumor within a critical isotherm. In addition, as the
distance between the cryoprobe and the optical fiber is
FIGURE 9. Images taken after a LAC procedure for different levels of the exposure values (EV): (a) EV 5 50, (b) EV 5 100,
(c) EV 5 150, (d) EV 5 200, (e) EV 5 250, and (f) EV 5 300.
FIGURE 10. Comparison of temperature histories between a
LAC procedure (solid lines) and a LAC procedure without
laser heating (dashed lines).
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reduced, steeper gradients can be achieved, since the
best protection occurs when the cryoprobe is placed
near the protected surface.31 Nevertheless, future work
in the development of LAC must address the obvious
problem of locating the optical fibers with enough
precision to achieve the desired gradients. This is an
optimization problem, in which the placement of the
optical fibers within the tissue and its location relative
to the cryoprobes are parameters that should be varied
to maximize the superficial tissue protection.
Since the absorption of laser energy is wavelength
dependent, the light distribution, penetration depth,
and resulting heat generation will depend on the laser
of choice. Although this study uses a wavelength of
1320 nm with an absorption coefficient of <0.13
(mm21),24 previous studies31,32 show that for infrared
wavelengths, even when most of the laser energy is
absorbed near the surface, the protection achieved by
laser heating is still better than the protection achieved
by conventional constant temperature heating tech-
niques. In addition, by having proper estimates on the
spectral optical properties of prostate, one may better
select a laser wavelength that provides a higher pene-
tration depth to increase the thickness of the protected
tissue, if required.
Correlation between the temperature histories and
the outcome of viability assays presented herein show
that the threshold for tissue thermal damage due to
cryoinjury using LAC is of Tth  4 C located at a
distance of 8.2 mm away from the cryoprobe tip.
Interestingly, this isotherm is located very close to the
interface between frozen and unfrozen tissue. This is
probably explained because the non-frozen tissue is
subject to continued metabolic derangement and the
periphery of the frozen tissue has a margin of partially
damaged tissue. Therefore, although this region has
been exposed to a sublethal freezing insult, this seems
to be enough to induce apoptosis. Since the safety
distance in cryosurgical procedures may be dramati-
cally reduced with LAC, the requirement to freeze
large zones surrounding the tumor to ensure complete
destruction may be reduced.
The implementation of LAC may eventually lead to
clinical improvements in the outcome of cryosurgery.
The implications of its implementation are:
i. Only one freeze/thaw cycle will be necessary.
The reason is because once steady-state heat
transfer is reached, the entire tumor is
encompassed in a lethal isotherm that ensures
tissue necrosis.
ii. There will be no need to stop the freezing
process prior to achieving the target lethal
temperature.
iii. The effective cryosurgical tissue destruction
zone will be enlarged by producing large
thermal gradients, particularly for larger
lesions that require overlapping cryoablation
zones.
Current research in cryosurgery is concerned with
finding a thermal procedure that will absolutely
destroy tissue. In this scenario, a new cryosurgical tech-
nique has been developed, whereby laser irradiation
combines with cryogenic freezing to selectively freeze
and better confine damage to cancerous tissue. This is
in contrast with most laser tissue heating applications,
where lasers are used for ablation and coagulation of
soft tissue rather than its preservation. In this study, the
thermal history obtained during freezing and thawing
in a LAC procedure has been measured. Our experi-
mental results demonstrate the feasibility of LAC for
providing thicker and controllable penetration depths.
Nevertheless, there are still many issues to address in
future research and development of LAC:
i. The time spent at the end-temperature during
steady-state heat transfer was not explicitly
studied in this work, since we limited this time
to 100 s. Further studies are required to verify
the influence of the duration of steady-state in
the thickness of the protection achieved.
ii. Although LAC is a promising new method-
ology to treat prostate cancer, significant
additional work will be necessary to develop
laser power regulation algorithms to control
the laser irradiation emitted from the urethra,
across its wall and into the prostate. Optimi-
zation of laser delivery can be achieved by
using a laser system that includes a thermal
feedback feature to automatically adjust the
laser energy so that a maximum temperature
within the tissue never exceeds a specified
temperature. In order to obtain improved
control, a temperature sensor has been used by
some to provide feedback for regulation of the
delivered energy, accomplished by switching
the laser on or off.10,15,23 The sensor can be
positioned at the border of the tumor and the
temperature kept constant at that position
through computer controlled feedback regu-
lation of the laser output.
iii. Development of an accurate deliverance of
laser energy needed to achieve the desired
protection of the inner wall of the prostate
surrounding the urethra. This can be accom-
plished by using FDA cleared modified fiber
optic probes for urethral soft tissue treatment
with 360 or side firing diffusion tips.
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iv. Optimization of the location of optical fibers
to enhance the sharpness in the ablative edges
must be developed before LAC can be imple-
mented in pre-clinical and clinical trials. This
can be accomplished by developing numerical
optimization techniques as in previous
works.1,2,19,36,37
The overall goals, not yet achievable with the
results from the present study are to provide a new
tool to develop a treatment modality that overcomes
the limitations of traditional prostate cancer cryo-
therapy, especially for large or irregularly shaped
tumors. By having the capability to shape the frozen
region to strict boundaries within which tissue
necrosis is ensured and beyond which viable and
healthy tissue prevails, it may be possible to eradi-
cate most of the major complications of cryosurgery,
such as sloughing (necrosis) of the prostatic urethra,
bladder neck contracture, incontinence, and impo-
tence. As most advances in medical technology, LAC
is expected to positively impact the therapeutic
outcome and, thus, the quality of life of many
patients.
The present results suggest that further studies
examining the feasibility of such a procedure in vivo
should be pursued. Such studies are currently under
way in our laboratory.
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